The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy
NCT02573636 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 208
Last updated 2024-12-04
Summary
The objective of the study is to evaluate the predictive value of TMPRSS2-ERG gene fusion and PTEN in patients with high risk prostate cancer treated with first line LHRH agonist after biochemical failure.
Conditions
Sponsors & Collaborators
-
Sir Mortimer B. Davis - Jewish General Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2026-11-30
- Completion
- 2027-03-31
Countries
- Canada
Study Locations
More Related Trials
-
Microarray Analysis of Gene Expression in Prostate Tissues
NCT00186368 ·Status: COMPLETED
-
Salvage Cryotherapy in Recurrent Prostate Cancer
NCT00824928 ·Status: TERMINATED
-
Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical Model
NCT03979079 ·Status: COMPLETED
-
Precision-Based Genomics in Prostate Cancer
NCT04706663 ·Status: RECRUITING
-
MR/TRUS Fusion Guided Prostate Biopsy
NCT04026763 ·Status: UNKNOWN ·Phase: NA
-
GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies
NCT07258056 ·Status: RECRUITING ·Phase: NA
-
Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.
NCT06523634 ·Status: RECRUITING ·Phase: NA
-
Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer
NCT01976962 ·Status: TERMINATED ·Phase: NA
-
Prostate Cancer Genetic Risk Evaluation and Screening Study
NCT05129605 ·Status: RECRUITING
-
PSMA-PET/CT Registry
NCT05709535 ·Status: TERMINATED
-
Timing of Post-prostatectomy PSMA Imaging
NCT05008900 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
NCT05477823 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Post-operative or Early Salvage XRT and ADT for High Risk PCa
NCT00949962 ·Status: TERMINATED ·Phase: PHASE3
-
A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy Approaches
NCT03632655 ·Status: TERMINATED ·Phase: NA
-
68Ga-PSMA PET/CT in Prostate Cancer
NCT03001869 ·Status: COMPLETED ·Phase: PHASE3
-
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
NCT06398639 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated SBRT For Prostate Cancer
NCT00977860 ·Status: COMPLETED ·Phase: NA
-
Circulating Tumor DNA in High Risk Localized Prostate Cancer
NCT07222436 ·Status: RECRUITING
-
Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer
NCT02869282 ·Status: WITHDRAWN
-
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
NCT00967889 ·Status: UNKNOWN
-
Epidemiologic and Genetic Study on Familial Prostate Cancer
NCT01221168 ·Status: RECRUITING
-
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
NCT05698576 ·Status: RECRUITING ·Phase: NA
-
Characterization of Prostate Cancer With 3T MR
NCT00831142 ·Status: ACTIVE_NOT_RECRUITING
-
MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy
NCT00775866 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T
NCT02232230 ·Status: COMPLETED